Amoxclan

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amoxclan

Quick Facts

Property Description
Active Ingredients Amoxicillin, Clavulanic Acid
Form Tablet, Oral Suspension, IV Injection
Pharmacological Class Beta-Lactam/Beta-Lactamase Inhibitor Combination
Common Use Treating Bacterial Infections
Origin Semisynthetic (Amoxicillin) & Microbial-Derived (Clavulanic Acid)

What Type of Medicine is Amoxclan?

Amoxclan is the trade name for the combination of Amoxicillin and Clavulanic Acid, known internationally as Co-amoxiclav. This is a prescription-only antibacterial agent classified as a beta-lactam/beta-lactamase inhibitor combination, a specialized category within the penicillin-like antibiotics. The drug is clinically recognized for its role in overcoming microbial defenses, which is supported by pharmacological data regarding the combination. Amoxclan is supplied in various oral and intravenous preparations, with forms like chewable tablets and extended-release tablets providing options for diverse patient needs.

Composition: Why Does Amoxclan Have Two Active Ingredients?

The formulation centers on the synergistic action between the antibiotic Amoxicillin and the enzyme inhibitor Clavulanic Acid (as Potassium Clavulanate). While Amoxicillin provides the primary bactericidal effect—killing bacteria by disrupting their cell walls—Clavulanic Acid serves a critical protective function. This strategic combination differentiates it from single-agent penicillins and is crucial for maintaining efficacy against resistant bacteria. It is widely known under commercial names like Augmentin in the US and Clavulin in Canada, demonstrating its global acceptance as a standard treatment for infections caused by defense-producing bacteria. The combination is recognized as critically important for human medicine due to its role in managing drug-resistant infections.

What is the General Purpose of Amoxclan?

The general therapeutic purpose of Amoxclan is to provide an enhanced, broad-spectrum defense against a variety of bacterial infections. This medicine is primarily used when there is suspicion or confirmation that the causative bacteria are producing beta-lactamase enzymes, which inactivate many common antibiotics. By combining Amoxicillin with its designated inhibitor, the medicine is capable of treating infections caused by a wider array of susceptible pathogens, ensuring the patient benefits from potent antibacterial activity against resistant strains.

Regulatory References

  1. The World Health Organization (WHO)

What side effects are possible with Amoxclan?

Possible Side Effects and Safety Information

The safety profile for Amoxclan (amoxicillin/clavulanate) is primarily defined by its potential for hypersensitivity reactions, gastrointestinal events, and liver toxicity, as documented in regulatory sources.

Common Adverse Reactions

The most frequently reported side effects in clinical trials, occurring in up to 1 in 10 patients, typically involve the gastrointestinal system and include diarrhea, nausea, and vomiting. Other common reactions are skin rash and mucocutaneous candidiasis.

Serious and Clinically Significant Adverse Reactions

Official regulatory documents classify several reactions as serious, requiring immediate discontinuation of the medication. These include:

  • Serious Hypersensitivity Reactions: Anaphylaxis, Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) are rare but require urgent medical care.
  • Hepatobiliary Toxicity: Cholestatic jaundice and hepatic dysfunction, which can be delayed or prolonged, are rare but serious. A history of these events associated with amoxicillin/clavulanate is an absolute contraindication for future use.
  • Clostridioides difficile-Associated Diarrhea (CDAD): This condition can occur during or up to two months after stopping therapy and requires medical evaluation.
  • Convulsions (Seizures): Rare events, more likely to occur in patients with impaired renal function or those receiving high doses.

Safety-Related Restrictions and Warnings

Amoxclan is formally contraindicated in patients with known allergies to penicillin or any beta-lactam antibiotic, or a history of liver problems linked to this specific medication. Use is generally avoided in patients with infectious mononucleosis due to an increased risk of developing a skin rash. Dose adjustments are required for patients with severe kidney impairment. Concomitant use with certain drugs, such as oral anticoagulants and Probenecid, may require monitoring or be generally not recommended due to potential effects on drug concentrations or blood clotting parameters.

Overdose and Emergency Response

Overdose and when to seek help

Overexposure to Amoxclan (amoxicillin and clavulanic acid) is primarily characterized by effects on the gastrointestinal and renal systems, alongside potential neurological manifestations, as defined in regulatory documentation.

Documented overdose presentations typically include pronounced gastrointestinal symptoms such as vomiting, diarrhea, and stomach pain, as well as central nervous system effects like somnolence (drowsiness) and hyperactivity. Urinary abnormalities, including cloudy urine, are also noted.


Severe Manifestations and Urgent Action

The official prescribing information highlights the risk of crystalluria, where amoxicillin precipitates in the urinary tract. This condition can potentially lead to renal failure. Patients with pre-existing impaired renal function or those receiving high doses are at an increased risk of convulsions following overdosage.

There is no specific antidote known for Amoxclan. Overdose management is limited to symptomatic and supportive treatment, including maintaining fluid balance and monitoring renal function. Hemodialysis is documented as an effective procedural method for removing the active components from the bloodstream.


Required Action Outcome that Mandates Immediate Help
Seek immediate medical attention. Any suspected overdose.
Call emergency services. If the person has experienced a seizure, collapse, has trouble breathing, or cannot be awakened.

Therapeutic Uses of Amoxclan

What Amoxclan Treats: Main Uses and Benefits

Amoxclan (amoxicillin and clavulanate) is applied in contexts where additional symptomatic support is needed. It is applicable within clinical settings that involve acute or disruptive symptom patterns and is relevant for managing symptoms that interfere with daily comfort, such as fever, localized pain, swelling, and systemic discomfort.

This medication is commonly used across conditions presenting with acute episodes within several therapeutic areas. These include infections of the ear, nose, and throat (e.g., severe sinusitis and otitis media), the lower respiratory tract (e.g., bronchitis and pneumonia), the skin and soft tissues (e.g., cellulitis and bite wounds), and the urinary tract.

“Amoxclan supports the patient during difficult episodes by easing distress and is commonly used when short-term symptomatic assistance is needed.”


Quick Fact: Relief for Heightened Discomfort

Amoxclan is often used during phases when symptoms become more noticeable, particularly in clinical settings that involve acute or unstable symptom patterns. It assists with maintaining functional stability and provides supportive relief when symptoms interfere with routine activities.

Eligibility and Restrictions for Use

Who Can and Cannot Use Amoxclan?

The official eligibility for Amoxclan (Amoxicillin/Clavulanate) is defined by regulatory bodies based on a patient's medical history, age, and organ function. Use is absolutely contraindicated in individuals with a history of serious hypersensitivity reactions (like anaphylaxis) to penicillins or any other beta-lactam antibacterial drugs, or a history of cholestatic jaundice/hepatic dysfunction specifically associated with prior Amoxclan use.

Eligibility and Restrictions

Population Group Regulatory Status
Allergy to Penicillins/Beta-lactams Contraindicated
Prior Amoxclan-induced Liver Injury Contraindicated
Infectious Mononucleosis Use Should Be Avoided
Severe Renal Impairment Restricted (Requires dose adjustment; high-dose forms not recommended)
Hepatic Impairment Use with Caution (Requires monitoring)
Pregnancy / Lactation Restricted (Use only if clearly needed)
Infants < 12 weeks Restricted (Only specific low-strength formulations recommended)

Standard use is permitted for adults and children weighing ge 40 kg who do not possess any of the contraindications or restrictions listed above. The 875 mg tablet form is generally not recommended for patients with a creatinine clearance less than 30 mL/min. Use in patients with Phenylketonuria is restricted based on specific formulations that contain aspartame.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the officially documented interaction patterns for Amoxclan (Amoxicillin/Clavulanic Acid) as stated in government regulatory prescribing information.

Documented Pharmacokinetic Interactions

Regulatory sources indicate interactions that affect the concentration of active ingredients in the body:

  • Probenecid: Co-administration is documented to increase and prolong the systemic exposure of Amoxicillin by decreasing its renal tubular secretion. Caution or avoidance is generally advised.
  • Methotrexate: Amoxclan may reduce the excretion of Methotrexate, potentially leading to increased toxicity of Methotrexate.
  • Mycophenolate Mofetil (MMF): A reduction in the pre-dose concentration of the active metabolite (MPA) has been reported with co-administration.

Pharmacodynamic Effects and Restrictions

Interactions that affect specific bodily functions or the efficacy of other products include:

  • Oral Anticoagulants (e.g., Warfarin): Regulatory labels note the potential for prolongation of prothrombin time (INR), advising careful monitoring during and immediately following treatment.
  • Allopurinol: Concomitant use with Amoxicillin is documented to increase the likelihood of developing allergic skin rash.
  • Live Attenuated Vaccines: Amoxclan may reduce the immunological effectiveness of the live attenuated Typhoid vaccine.

Food and Laboratory Interference

  • Food: While immediate-release formulations may be taken without regard to meals, the extended-release tablets must be administered with a meal.
  • Laboratory Tests: Amoxclan may cause false-positive results for urine glucose tests (non-enzymatic methods) and can lead to a false-positive Coombs test.

Mechanism of Action

Amoxclan is a fixed-dose combination composed of amoxicillin, a beta-lactam antibiotic, and clavulanic acid, a beta-lactamase inhibitor.

Amoxicillin's primary biological targets are the bacterial penicillin-binding proteins (PBPs), which function as DD-transpeptidases. Amoxicillin is an irreversible inhibitor that binds covalently to the active site of PBPs located on the inner bacterial cell membrane. This molecular interaction prevents the transpeptidation and cross-linking of peptidoglycan chains, which is the final step in bacterial cell wall biosynthesis.

The downstream intracellular consequence is the failure to assemble a structurally rigid cell wall, leading to osmotic instability and subsequent bacterial cell lysis.

Clavulanic acid acts as a suicide inhibitor against various bacterial beta-lactamase enzymes. It contains a beta-lactam ring that is hydrolyzed by the beta-lactamase, forming a stable, inactive acyl-enzyme intermediate. This interaction protects amoxicillin from enzymatic degradation by beta-lactamases, thereby preserving its concentration and enabling its inhibitory action on the PBPs. The system-level physiological consequence is the modulation of bacterial growth and viability by two complementary mechanisms of enzyme inhibition.

Dosage and Administration Information

Administration Routes and Timing

Amoxclan is administered through the oral route (tablets, extended-release tablets, and suspension) or the intravenous (IV) route in clinical settings. Standard administration practice involves taking oral doses at the start of a meal. This procedural condition is utilized to optimize the absorption of the clavulanic acid component and minimize potential gastrointestinal discomfort.


Official Dosing Regimens and Frequency

Dosing ranges are typically determined based on the severity of the infection and the specific formulation. Adult standard doses typically fall into twice-daily (BID) or three-times-daily (TID) schedules, with specific tablet strengths ranging, for example, up to 875/125 mg per dose. The use of the extended-release tablet is restricted to a BID schedule. The dosage of the clavulanic acid component is fixed at a low level in most formulations to govern the total allowed daily intake.


Duration and Special Administration Rules

The standard course of administration for Amoxclan is typically 7 to 10 days, and standard practice involves ensuring treatment does not exceed 14 days without clinical reassessment. Certain specialized forms, such as extended-release tablets, must be swallowed whole and cannot be crushed, chewed, or split. For patients with severely impaired renal function (creatinine clearance < 30 mL/min), clinical protocols include dose reductions or the restriction of certain high-dose formulations. Pediatric dosing is derived from the patient's body weight (mg/kg).

Recent Clinical Evidence

Amoxclan: Recent Clinical Evidence

Amoxclan is a combination antibiotic comprising amoxicillin and clavulanic acid. Research focuses on its ability to address bacterial infections, particularly those caused by bacteria that produce enzymes (beta-lactamases) that typically deactivate amoxicillin alone. Clavulanic acid helps preserve amoxicillin's activity against these resistant strains.


Clinical Trial Focus Areas

Recent clinical studies and meta-analyses have evaluated the use of this combination in the management of various bacterial infections. Key areas of investigation include:

  • Respiratory Infections: Randomized trials have been conducted to compare the clinical effect of Amoxclan against other regimens for conditions like community-acquired pneumonia (CAP) in adult and elderly populations. Studies have also explored the use of the combination for managing acute exacerbations of chronic bronchitis.
  • Dosing Regimens: Research has investigated whether high-dose, pharmacokinetically enhanced formulations, sometimes given in shorter courses (e.g., 5 days), maintain comparable clinical success rates to standard formulations administered over longer periods (e.g., 7 days) for conditions like acute exacerbations of chronic bronchitis.
  • Surgical Prophylaxis: Systematic reviews indicate that administration of amoxicillin and clavulanic acid is associated with a reduced risk of infection following certain surgical procedures, such as impacted third molar surgery.

Safety and Tolerability Summary

Clinical data consistently show that adverse events are predominantly gastrointestinal in nature. The most commonly reported events across studies include diarrhea, nausea, and vomiting. Rare but serious events, such as hypersensitivity reactions (including severe skin reactions) and drug-induced liver injury, have been reported in post-marketing surveillance.

Frequently Asked Questions (FAQ)

Common questions about Amoxclan (FAQ)

Q: What is the main difference between Amoxclan and amoxicillin alone?

A: Amoxclan is a specialized combination product. It contains the antibiotic amoxicillin along with clavulanic acid. Official product information indicates that clavulanic acid is included to protect amoxicillin from being destroyed by certain bacteria, which helps the medicine work against a wider range of infections.


Q: How quickly should I expect to feel better after starting Amoxclan?

A: According to official patient information, individuals typically begin to feel better during the first few days of treatment. If symptoms do not improve or if they become worse after this initial period, contacting the prescribing healthcare professional is generally advised.


Q: Does Amoxclan work for viral infections?

A: No. Amoxclan is a combination antibacterial drug. Official prescribing information clearly states that it is indicated only for infections caused by bacteria, and it is not effective against viral infections, such as the common cold or flu.


Q: What happens if I stop taking Amoxclan before the prescribed time?

A: Regulatory guidance emphasizes that completing the full prescribed course is typically advised. Stopping therapy prematurely can decrease the overall effectiveness of the treatment and is known to increase the risk that bacteria may develop drug resistance.


Q: Is a metallic taste in the mouth a known side effect of Amoxclan?

A: The list of potential side effects from regulatory sources includes taste disturbances (sometimes listed as uncommon). These changes to the sense of taste may include sensations such as a metallic or unpleasant taste.


Q: Can Amoxclan cause changes in mood or behavior?

A: Official labeling lists certain effects on the central nervous system (CNS) as possible adverse reactions. These may include reversible effects such as dizziness, anxiety, insomnia, and, rarely, convulsions. If significant changes in mood or behavior are observed, seeking medical attention is important.


Q: Why is it important to take Amoxclan at evenly spaced intervals?

A: Taking the dose at evenly spaced intervals, such as every 12 hours for a twice-daily schedule, is necessary to maintain a consistent level of the antibiotic in the bloodstream. This steady concentration is critical for effectively fighting the bacterial infection throughout the entire course of therapy, as outlined in regulatory guidance.


Q: Is it possible to develop a resistance to Amoxclan over time?

A: Yes. Regulatory warnings address the potential for bacteria to develop resistance to antibacterial drugs. For this reason, official guidance emphasizes that the medication is intended only for infections caused by susceptible bacteria, and completing the prescribed course is often advised.


Q: What should I do if I accidentally miss a dose of Amoxclan?

A: If the missed dose is remembered, it is generally advised to take it as soon as possible. However, if it is almost time for the next scheduled dose, the dose may be skipped to continue with the regular schedule. Official patient information advises against taking a double dose to compensate for a missed one.


Q: What happens if I accidentally take a dose of Amoxclan too close to the last one?

A: Taking doses too closely together can result in a higher-than-intended concentration of the medication, which may increase the risk of certain side effects, particularly gastrointestinal discomfort. Following the prescribed time intervals between doses is intended to minimize this risk.


Q: Is there a generic version of Amoxclan available?

A: Yes. The active components—amoxicillin and clavulanate potassium—are available as a generic combination from various manufacturers, which are typically listed alongside the brand name product in regulatory databases like DailyMed.


Q: Does Amoxclan lose effectiveness if it's not stored correctly?

A: Yes. Official storage instructions must be followed carefully to maintain the drug’s stability and effectiveness. For example, tablets must be protected from moisture and heat, and the oral suspension typically requires refrigeration and must be discarded after 10 days.


Q: What is the shelf life of Amoxclan tablets?

A: The shelf life of Amoxclan tablets, when stored properly in the original, unopened packaging, is typically two years from the date of manufacture. Once a protective foil pouch containing the tablets is opened, the tablets often need to be used within a shorter period, such as 30 days.


Q: What is the average time for Amoxclan to be completely out of my system?

A: The active components have a short half-life, meaning the concentration of the drug in the body decreases rapidly. The half-life is approximately one hour, and it usually takes about five to six half-lives for the drug to be largely cleared from the body.


Q: Can I take Amoxclan if I have kidney problems?

A: Dose adjustments may be necessary in the presence of kidney problems. The body’s ability to clear the drug slows down in patients with reduced kidney function. Official labeling mandates a dose reduction or restriction of certain high-dose formulations if severe renal impairment is present.


Q: Can I take Amoxclan if I have liver problems?

A: If there is a history of liver injury or cholestatic jaundice specifically linked to previous use of this drug, the medication is absolutely contraindicated. For other types of hepatic (liver) impairment, the medicine may be used with caution, and hepatic function monitoring may be required.


Q: Is Amoxclan safe to take during pregnancy (general question)?

A: Regulatory sources advise that data on its use during pregnancy are limited. Use during pregnancy is advised only if a healthcare provider determines it is clearly needed and the potential benefit of treating the infection outweighs any potential risk.


Q: Can Amoxclan be used to treat dental infections?

A: Yes, official therapeutic indications for Amoxclan include the treatment of certain bacterial infections in the body. Specific regulatory prescribing information lists odontogenic infections, such as a dentoalveolar abscess, as an approved use.


Q: Why might a doctor prescribe Amoxclan instead of a different antibiotic?

A: The primary reason for selecting Amoxclan is often its ability to combat bacteria that produce beta-lactamase enzymes. Since the clavulanic acid protects the amoxicillin, this combination is typically prescribed when resistance to amoxicillin alone is confirmed or strongly suspected.


Q: Why is Amoxclan only available by prescription?

A: Amoxclan is classified as a prescription-only medicine because its use requires medical supervision. This is due to the potential for serious adverse effects, such as allergic reactions, and the need for a professional diagnosis to ensure the drug is appropriate for the specific type of bacterial infection.


Q: What are the different strengths of Amoxclan, and why?

A: Amoxclan is produced in various strengths (e.g., 500/125 mg and 875/125 mg) and in different ratios of amoxicillin to clavulanic acid. These variations allow healthcare providers to select the appropriate dose based on the severity and type of infection, while also controlling the total daily intake of the clavulanic acid component.


Q: Why is Amoxclan sometimes used for respiratory tract infections?

A: Amoxclan is officially approved for the treatment of certain respiratory tract infections. This includes conditions like acute bacterial sinusitis and community-acquired pneumonia, particularly when the causative bacteria are known to be sensitive to the drug's combination of active ingredients.


Q: Can I drink coffee or tea while I'm on Amoxclan?

A: Official instructions advise taking the dose at the start of a meal or with a snack to help with absorption and minimize stomach upset. Since coffee and tea are not listed as specific contraindications, they can typically be consumed, but it is generally advised to take the dose with a meal or a full glass of water or milk.


Q: Are there any specific foods I should avoid while using Amoxclan?

A: Regulatory information does not list specific foods to avoid while taking Amoxclan. The general guidance is to continue a normal diet while ensuring the medication is taken with a meal or snack to aid absorption and help reduce the chances of gastrointestinal intolerance.


Q: What should I do if my symptoms don't improve after a few days on Amoxclan?

A: If there is no improvement in symptoms, or if the condition appears to worsen after a few days of treatment, contacting the prescribing healthcare provider is necessary for reassessment.


Q: Can Amoxclan be crushed or chewed, or must it be swallowed whole?

A: This depends on the formulation. Official product instructions mandate that extended-release tablets must be swallowed whole and cannot be crushed or split. If chewable tablets are prescribed, they must be thoroughly chewed before swallowing. Standard immediate-release tablets are generally swallowed whole.


Q: Are there any long-term side effects associated with Amoxclan use?

A: Official treatment guidelines restrict the duration of treatment to a maximum of 14 days without clinical reassessment, which inherently limits its long-term use. Serious side effects, such as hepatic dysfunction and C. difficile-associated diarrhea, have been reported to occur even after treatment has finished.


Q: Is it normal to feel tired or dizzy while taking Amoxclan?

A: Official labeling lists dizziness as a possible adverse effect. Tiredness (fatigue) is not consistently listed as a common side effect. Because dizziness can affect the ability to drive or operate machinery, caution is advised if this effect is experienced.


Q: Can older adults take Amoxclan without special precautions?

A: Regulatory sources advise caution for older adults. Due to the higher likelihood of decreased kidney function in this population, dose selection may require careful adjustment, and monitoring of kidney function may be required.


Q: Why do some people get diarrhea from Amoxclan?

A: Diarrhea is one of the most common side effects listed. Regulatory warnings explain that it can sometimes be a sign of Clostridioides difficile-associated diarrhea (CDAD). This occurs when the antibiotic disrupts the normal, healthy bacteria in the colon, allowing a harmful bacterium to overgrow.


Q: Is Amoxclan the same as Augmentin?

A: Yes, in terms of active ingredients. Augmentin is a well-known brand name for the generic combination of amoxicillin and clavulanate potassium. Amoxclan contains the exact same two active components, making them chemically equivalent.

How should Amoxclan be stored and disposed of?

How to Store and Dispose of Amoxclan

Storage requirements for Amoxclan (amoxicillin and clavulanate potassium) differ based on the product form:

  • Tablets and Dry Powder: Must be stored at Controlled Room Temperature, between 20°C and 25°C. These forms require storage in the original container, which must be kept tightly closed to protect the contents from light and moisture.
  • Reconstituted Oral Suspension: Requires storage in a refrigerator (2°C to 8°C) and must be kept from freezing. The suspension must be discarded after 10 days from the time of mixing.

All forms of this medicine must be kept out of the reach and sight of children.

Disposal

Unused or expired Amoxclan should be disposed of according to governmental guidelines, such as utilizing an official drug take-back program. If a take-back option is unavailable, the product should be mixed with an undesirable substance and sealed for disposal in the household trash, as it is not recommended for flushing.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amoxclan found in:

A-Z Index: